Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001231919-25-000596

10% owner sold 4,175,139 shares at an average $13.98 ($58,377,021)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
RA CAPITAL MANAGEMENT, L.P. 10% owner 2025-12-08 Sale −1,377,020 $13.33 $18,355,677 8,852,079 I
RA CAPITAL MANAGEMENT, L.P. 10% owner 2025-12-08 Sale −2,706,397 $14.28 $38,647,349 6,145,682 I
RA CAPITAL MANAGEMENT, L.P. 10% owner 2025-12-08 Sale −91,722 $14.98 $1,373,996 6,053,960 I
Open-market sales · 4,175,139 sh · avg $13.98 · $58,377,021
Loading xslF345X05/form4-12102025_091221.xml…